Full Text View
Tabular View
No Study Results Posted
Related Studies
FGF-23 Suppressibility by Calcitonin
This study is currently recruiting participants.
Study NCT00688077   Information provided by Rijnstate Hospital
First Received: May 28, 2008   Last Updated: May 30, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypophosphatemia
More general conditions related to this trial
Metabolic Diseases
Phosphorus Metabolism Disorders
Interventions listed in this trial
Calcitonin
Placebo
Additional drug interventions recognized in this trial
Calcitonin Gene-Related Peptide
Salmon calcitonin
More general drug interventions related to this trial
Bone Density Conservation Agents
Cardiovascular Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Rijnstate Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services